Exforge Tablet, Film Coated
Product Images NDC 0078-0490

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Exforge (NDC 0078-0490). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Exforge 01)

A line graph comparing the percentage of systolic blood pressure (SBP) less than 140 mmHg over baseline systolic blood pressure (SBP in mmHg) among different treatments: Exforge 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and Placebo. The graph shows blood pressure response across a baseline SBP range from 140 to 180 mmHg.*

FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Exforge 02)

A line graph comparing the percentage of patients with blood pressure less than 90 mmHg across different baseline diastolic blood pressure values (96 to 110 mmHg). It includes data lines for Exforge (10/320 mg), Valsartan 320 mg, Amlodipine 10 mg, and Placebo, showing their relative efficacy in lowering blood pressure.*

FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Exforge 03)

A line chart showing the percent systolic blood pressure (SBP) under 120 mm Hg plotted against baseline SBP in mm Hg. The chart includes four groups: Exforge 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and Placebo, each represented by different symbols. The graph illustrates comparative data points for these treatments across a range of baseline SBP values from 140 to 180 mm Hg.*

FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Exforge 04)

A chart comparing the percentage of patients with expanded blood pressure (EBP) below 80 mmHg across different baseline diastolic blood pressure (DBP) levels (95 to 110 mmHg). The chart includes data series for Exforge 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo, illustrating their effects on EBP relative to baseline DBP.*

FDA Label Image

Amlodipine Besylate Structural Formula (Exforge 05)

Chemical structure diagram showing molecular formulas and bonding of an active pharmaceutical ingredient, likely representing one of the components of Exforge (amlodipine besylate and valsartan) based on the product data.*

FDA Label Image

Valsartan Structural Formula (Exforge 06)

Chemical structure of amlodipine besylate, one of the active ingredients in Exforge tablets.*

FDA Label Image

Principal Display Panel Ndc 0078-0488-15 Exforge® (amlodipine And Valsartan) Tablets 5 mg*/160 mg *each Tablet Contains 6.9 mg Of Amlodipine Besylate 30 Tablets Rx Only Novartis (Exforge 07)

Exforge 5 mg/160 mg film-coated tablets label showing the brand name and generic names amlodipine and valsartan. The label indicates a package of 30 tablets, prescription only, manufactured by Novartis Pharmaceuticals Corporation, with storage and usage instructions included.*

FDA Label Image

Principal Display Panel Ndc 0078-0489-15 Exforge® (amlodipine And Valsartan) Tablets 10 mg*/160 mg *each Tablet Contains 13.9 mg Of Amlodipine Besylate 30 Tablets Rx Only Novartis (Exforge 08)

Exforge 10 mg/160 mg film-coated tablets label showing the active ingredients amlodipine besylate and valsartan. The package contains 30 tablets, labeled for prescription use only. The label includes the NDC number, storage instructions, manufacturer Novartis Pharmaceuticals Corporation, and other regulatory information.*

FDA Label Image

Principal Display Panel Ndc 0078-0490-15 Exforge® (amlodipine And Valsartan) Tablets 5 mg*/320 mg *each Tablet Contains 6.9 mg Of Amlodipine Besylate 30 Tablets Rx Only Novartis (Exforge 09)

Exforge 5 mg/320 mg film-coated oral tablets label by Novartis Pharmaceuticals Corporation. The label specifies each tablet contains 6.9 mg of amlodipine besylate and comes in a package of 30 tablets. The label includes NDC 0078-0490-15 and standard storage instructions, along with regulatory and manufacturing details.*

FDA Label Image

Principal Display Panel Ndc 0078-0491-15 Exforge® (amlodipine And Valsartan) Tablets 10 mg*/320 mg *each Tablet Contains 13.9 mg Of Amlodipine Besylate 30 Tablets Rx Only Novartis (Exforge 10)

Exforge 10 mg/320 mg film-coated tablets label shows the product name with active ingredients amlodipine besylate and valsartan. The label indicates 30 tablets per package, prescription use only, and the manufacturer as Novartis Pharmaceuticals Corporation. Storage information and package identification details are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.